Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados 55 (3) Autor Turchi,Marília Dalva (3) Martelli,Celina Maria Turchi (2) Batista,Lindon Johnson de Abreu (1) Brandão,Natália Alberto Alves (1) Guilarde,Adriana Oliveira (1) Martelli,Celina M. Turchi (1) Nery,Max Weyler (1) Pfrimer,Irmtraut Araci Hoffmann (1) Primo,Mariusa Gomes Borges (1) Mais... Palavra-chave HIV (2) Prevalence (2) AIDS (1) Attributable mortality (1) Bloodstream infection (1) Co-infection (1) Dyslipidemia (1) Extra costs (1) HAART (1) Hepatitis (1) Length of stay (1) Staphylococcus aureus (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Info:eu-repo/semantics/other (1) Ano 2015 (1) 2012 (1) 2011 (1) País Brazil (3) Idioma Inglês (3)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 3 Primeira ... 1 ... Última Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs 55 Primo,Mariusa Gomes Borges; Guilarde,Adriana Oliveira; Martelli,Celina M. Turchi; Batista,Lindon Johnson de Abreu; Turchi,Marília Dalva. This study aimed to determine the excess length of stay, extra expenditures, and attributable mortality to healthcare-associated S. aureus bloodstream infection (BSI) at a teaching hospital in central Brazil. The study design was a matched (1:1) case-control. Cases were defined as patients &gt; 13 years old, with a healthcare-associated S. aureus BSI. Controls included patients without an S. aureus BSI, who were matched to cases by gender, age (± 7 years), morbidity, and underlying disease. Data were collected from medical records and from the Brazilian National Hospital Information System (Sistema de Informações Hospitalares do Sistema Único de Saúde - SIH/SUS). A Wilcoxon rank sum test was performed to compare length of stay and costs between cases... Tipo: Info:eu-repo/semantics/article Palavras-chave: Staphylococcus aureus; Bloodstream infection; Attributable mortality; Length of stay; Extra costs. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600001 Dyslipidemia in AIDS patients on highly active antiretroviral therapy 55 Nery,Max Weyler; Martelli,Celina Maria Turchi; Turchi,Marília Dalva. Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however it has been associated with metabolic abnormalities. This study estimated the prevalence of lipid abnormalities and related factors among patients on HAART. A cross-sectional study was conducted on adult patients, in central Brazil. Patients were interviewed, and blood obtained for lipids measurement. Dyslipidemia was defined as total cholesterol (TC) &gt; 240 mg/dL, low-density lipoprotein (LDL) &gt; 160 mg/dL, triglycerides (TG) &gt; 200 and/or high-density lipoprotein (HDL) < 40 mg/dL. Multiple logistic regression analyses were performed (SPSS 13.0). One hundred and thirteen patients were recruited. Mean age was 39.3 years; 68.1% were males;... Tipo: Info:eu-repo/semantics/article Palavras-chave: Prevalence; Dyslipidemia; HIV; AIDS; HAART. Ano: 2011 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000200010 Prevalence of hepatitis B and C infection and associated factors in people living with HIV in Midwestern Brazil 55 Brandão,Natália Alberto Alves; Pfrimer,Irmtraut Araci Hoffmann; Martelli,Celina Maria Turchi; Turchi,Marília Dalva. This study aimed to estimate the prevalence of infection by the hepatitis B virus (HBV) and hepatitis C virus (HCV) in people infected by the human immunodeficiency virus (HIV) and analyze sociodemographic and behavioral factors associated with such co-infection. A cross-section study was performed in 495 individuals treated at a public center in the city of Goiânia. Participants were interviewed and blood collected for evaluation of serological and molecular markers for HBV and HCV. The rate of exposure to HBV was 33.5% (95% CI 29.4-37.9). Nineteen patients (3.8%) were diagnosed as HBV carriers, of whom 68.4% were HBV DNA positive. The prevalence of anti-HCV was 9.7% (95% CI 7.3-12.7). Genotype 1a was identified in 72.7% of the PCR samples positive for HCV.... Tipo: Info:eu-repo/semantics/other Palavras-chave: HIV; Hepatitis; Co-infection; Prevalence. Ano: 2015 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702015000400426 Registros recuperados: 3 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco